Bluebird Bio (NQ: BLUE )
0.6887
+0.0117
(+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Bluebird Bio
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 18, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://mms.businesswire.com/media/20230117006171/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
From bluebird bio, Inc.
Via Business Wire
![](https://g.foolcdn.com/editorial/images/711617/patient-sitting-on-hospital-bed.jpg)
Looking Into bluebird bio's Return On Capital Employed
November 30, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7192.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230109005284/en/744394/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://g.foolcdn.com/editorial/images/715245/patient-talking-with-a-physician.jpg)
![](https://mms.businesswire.com/media/20230106005087/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Sells Second Priority Review Voucher for $95 Million
January 06, 2023
From bluebird bio, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/01/05/pill-_image_by_arek_socha_from_pixabay_.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230105005532/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
From bluebird bio, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230103005203/en/744394/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
From bluebird bio, Inc.
Via Business Wire
![](https://g.foolcdn.com/editorial/images/714458/investors-watch-a-presentation-around-a-table.jpg)
![](https://g.foolcdn.com/editorial/images/713791/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/19/blue_logo_light__1624b39f83a9fa5bb91803f2d607e59a.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/blue-1600.png)
![](https://mms.businesswire.com/media/20221219005245/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/13/magenta-logo-color-png.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/712778/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg)
![](https://mms.businesswire.com/media/20221210005011/en/744394/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://public.newsdirect.com/921481264/9k3wzirG.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_75217473_S.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/blue_logo_light__1624b39f83a9fa5bb91803f2d607e59a.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221130005434/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Sells Priority Review Voucher for $102 Million
November 30, 2022
From bluebird bio, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/11/23/77d555b1-6d49-48f7-8f99-67954a7a9e69.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/709891/physician-shaking-patients-hand.jpg)
![](https://g.foolcdn.com/editorial/images/709470/patient-sitting-on-hospital-bed.jpg)
2 Growth Stocks That Could Double in 2023
November 17, 2022
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.